TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases and pain, today announced a partnership with LifeArc®, the UK-based medical research charity. The collaboration brings together the drug discovery skills of TetraGenetics with the antibody humanization and development capabilities of LifeArc. Under the agreement LifeArc will humanize up to five new drug leads discovered by TetraGenetics and may support pre-IND (Investigational New Drug) studies for selected programs. TetraGenetics will manage the regulatory applications and the subsequent clinical trials […]
A Springfield boy hosted a thank you concert for the community who helped him raise funds for his eSight glasses. Read more >>
Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies.
In episode four, Moukheiber and Powsner chat with Jack Langworthy, of Covington Associates, as he looks at startups from an investment banker’s perspective. Tune in >>
Dan Aziz stood outside of pharmacies surveying pregnant women for market research before starting his company, Luna Pharmaceuticals, which developed Premama. Read more >>
TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1Ziad
TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases, today announced a collaboration with ModiQuest Research, a Dutch biotechnology company with a suite of technologies for the discovery and optimization of monoclonal antibodies including those directed against difficult target antigens with low immunogenicity. Read more >>
Myomo, Inc. Announces Full Exercise of Underwriter’s Over-Allotment Option in Follow-On Public OfferingZiad
Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that Roth Capital Partners, the underwriter of Myomo’s follow-on offering, exercised in full its option to purchase 626,250 shares of common stock and accompanying warrants to purchase 626,250 shares of common stock, at a combined price to the public of $2.40 per share of common stock and accompanying warrant, for gross proceeds of approximately $1.5 million. Read more >>
Two Babson Alumni Businesses to Appear on ‘Meet the Drapers’—a New TV Show Turning Viewers into InvestorsZiad
Green Piñata will appear in Episode Four on Sunday, December 10 at 6 p.m. ET. Read more >>
With community’s help, legally blind Springfield teen now can see world through new electronic glassesZiad
Reilly Gault, 15, has been legally blind for the majority of his life.
But on Friday evening, that all changed — Gault now can see.
Gault, 15, recently asked the community for some help to raise $10,000 so he could purchase computerized glasses that allow him to see the world through a new and clearer lens. The community responded with a resounding “yes” and donated more than enough to cover the cost of the electronic glasses, made by Canadian-based company eSight. […]
Myomo, Inc. (MYO) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $2.21, down from yesterday’s close by -24.04%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data. Read more >>